Literature DB >> 28639079

Autonomic Nervous System Response to Stressors in Newly Diagnosed Patients with Multiple Sclerosis.

Miroslav Vlcek1,2, Adela Penesova3, Richard Imrich3, Milada Meskova3, Martina Mravcova3, Lucia Grunnerova4, Alexandra Garafova5,6, Monika Sivakova4, Peter Turcani4, Branislav Kollar4, Daniela Jezova6.   

Abstract

Autonomic dysfunction is commonly detected in patients with multiple sclerosis (MS). However, data evaluating autonomic nervous system function in early MS are limited. Present study investigates response to two different stressors in newly diagnosed MS patients, looking for the signs of autonomic dysfunction at the beginning of the disease. We examined 19 MS patients and 19 age, sex, and body mass index matched healthy controls. MS patients were newly diagnosed, untreated, and with low expanded disability status scale (EDSS) values [median 1.0 (interquartile range 1.0-1.5)]. Two stressors were used to evaluate the response of autonomic nervous system: Stroop word-color interference mental stress test and orthostasis. Plasma levels of epinephrine and norepinephrine, blood pressure (BP), and heart rate variability (HRV) parameters were evaluated. At the end of Stroop test MS patients had lower systolic BP (121 ± 15 vs. 132 ± 17 mmHg, p = 0.044), lower heart rate (79 ± 9 vs. 88 ± 16 1/min, p = 0.041), and lower epinephrine increment (10 ± 22 vs. 30 ± 38 pg/ml; p = 0.049) compared to healthy controls. Norepinephrine response was unaffected in MS, however, with lower norepinephrine levels during the test (p = 0.036). HRV parameters were similar in both groups. No differences in BP, heart rate, catecholamines, and HRV parameters between groups during orthostatic testing were found. We found slightly diminished sympathetic response to mental stress test, but unchanged response to orthostasis, in newly diagnosed untreated MS patients. The results suggest that autonomic dysfunction in MS is connected with more developed disease.

Entities:  

Keywords:  Autonomic dysfunction; Autonomic nervous system; Catecholamines; Heart rate variability; Multiple sclerosis; Stress

Mesh:

Substances:

Year:  2017        PMID: 28639079     DOI: 10.1007/s10571-017-0511-3

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  28 in total

1.  Cardiovascular autonomic dysfunction in multiple sclerosis: correlation with orthostatic intolerance.

Authors:  P Flachenecker; A Wolf; M Krauser; H P Hartung; K Reiners
Journal:  J Neurol       Date:  1999-07       Impact factor: 4.849

2.  Cardiovascular autonomic function in patients with relapsing remitting multiple sclerosis: a new surrogate marker of disease evolution?

Authors:  K Nasseri; B M Uitdehaag; M A van Walderveen; H J Ader; C H Polman
Journal:  Eur J Neurol       Date:  1999-01       Impact factor: 6.089

3.  Cardiovascular and sympathetic responses to a mental stress task in young patients with hypertension and/or obesity.

Authors:  A Garafova; A Penesova; E Cizmarova; A Marko; M Vlcek; D Jezova
Journal:  Physiol Res       Date:  2014       Impact factor: 1.881

4.  Early cognitive impairment along with decreased stress-induced BDNF in male and female patients with newly diagnosed multiple sclerosis.

Authors:  Barbora Prokopova; Natasa Hlavacova; Miroslav Vlcek; Adela Penesova; Lucia Grunnerova; Alexandra Garafova; Peter Turcani; Branislav Kollar; Daniela Jezova
Journal:  J Neuroimmunol       Date:  2016-11-19       Impact factor: 3.478

5.  Autonomic dysfunction in clinically isolated syndrome suggestive of multiple sclerosis.

Authors:  Luka Crnošija; Ivan Adamec; Mila Lovrić; Anamari Junaković; Magdalena Krbot Skorić; Ivo Lušić; Mario Habek
Journal:  Clin Neurophysiol       Date:  2015-06-16       Impact factor: 3.708

6.  Reduced spontaneous sympathetic nerve activity in multiple sclerosis patients.

Authors:  David M Keller; Paul J Fadel; Melissa A Harnsberger; Gina M Remington; Elliot M Frohman; Scott L Davis
Journal:  J Neurol Sci       Date:  2014-07-01       Impact factor: 3.181

7.  Heart rate variability and catecholamines during hypoglycemia and orthostasis.

Authors:  Miroslav Vlcek; Zofia Radikova; Adela Penesova; Richard Kvetnansky; Richard Imrich
Journal:  Auton Neurosci       Date:  2008-09-14       Impact factor: 3.145

8.  Multiple sclerosis.

Authors:  Alastair Compston; Alasdair Coles
Journal:  Lancet       Date:  2008-10-25       Impact factor: 79.321

9.  Altered cardiovascular reactivity to mental stress in patients with multiple sclerosis.

Authors:  Renan B Domingues; T H Carvalho; D V Vassallo; S C A Domingues; A L Teixeira
Journal:  Neurol Sci       Date:  2014-03-13       Impact factor: 3.307

10.  Time matters - acute stress response and glucocorticoid sensitivity in early multiple sclerosis.

Authors:  Simone Kern; Nicolas Rohleder; Graeme Eisenhofer; Jan Lange; Tjalf Ziemssen
Journal:  Brain Behav Immun       Date:  2014-05-29       Impact factor: 7.217

View more
  3 in total

Review 1.  Heart rate variability and fatigue in MS: two parallel pathways representing disseminated inflammatory processes?

Authors:  Guadalupe Garis; Michael Haupts; Thomas Duning; Helmut Hildebrandt
Journal:  Neurol Sci       Date:  2022-09-20       Impact factor: 3.830

Review 2.  The Link Between Energy-Related Sensations and Metabolism: Implications for Treating Fatigue.

Authors:  Marco Filippi; Rainer Krähenmann; Patrick Fissler
Journal:  Front Psychol       Date:  2022-06-21

Review 3.  Cardiac Autonomic Dysfunction in Multiple Sclerosis: A Systematic Review of Current Knowledge and Impact of Immunotherapies.

Authors:  Oliver Findling; Larissa Hauer; Thomas Pezawas; Paulus S Rommer; Walter Struhal; Johann Sellner
Journal:  J Clin Med       Date:  2020-01-24       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.